References
- James PA , OparilS, CarterBLet al. 2014 evidence-based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8) . JAMA311, 507 – 520 ( 2014 ).
- Wright JT Jr , FineLJ, LacklandDT, OgedegbeG, Dennison-HimmelfarbC . Evidence supporting a systolic blood pressure goal of less than 150 mmHg in patients aged 60 years or older: the minority view . JAMA311 ( 5 ), 507 – 520 ( 2014 ).
- SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension . Final results of the Systolic Hypertension in the Elderly Program (SHEP) . JAMA265, 3255 – 3264 ( 1991 ).
- Beckett NS , PetersR, FletcherAEet al. Treatment of hypertension in patients 80 years of age or older . N. Engl. J. Med.358, 1887 – 1898 ( 2008 ).
- Aronow WS , FlegJL, PepineCJet al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension . J. Am. Coll. Cardiol.57, 2037 – 2114 ( 2011 ).
- Mancia G , FagardR, NarkiewiczKet al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) . Eur. Heart J.34, 2159 – 2219 ( 2013 ).
- Banach M , BromfieldS, HowardGet al. Optimal blood pressure levels in elderly persons in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study . Presented at : 2013 European Society of Cardiology (ESC) Meeting, Hot Line-Clinical Trial Update Sessions.Amsterdam, The Netherlands, 1 September 2013 .
- Banach M , SerbanC, AronowWSet al. Lipid, blood pressure and kidney update 2013 . Int. Urol. Nephrol.46 ( 5 ), 947 – 961 ( 2014 ).
- Banach M , BromfieldS, HowardGet al. Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication . Int. J. Cardiol.176, 219 – 226 ( 2014 ).
- Lloyd-Jones DM , EvansJC, LevyD . Hypertension in adults across the age spectrum: current outcomes and control in the community . JAMA294, 466 – 472 ( 2005 ).
- KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease . Chapter 3 . Blood pressure management in CKD ND patients without diabetes mellitus . Kidney Int. Suppl.2, 357 – 362 ( 2012 ).
- KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease . Chapter 4 . Blood pressure management in CKD ND patients with diabetes mellitus . Kidney Int. Suppl.2, 363 – 369 ( 2012 ).
- American Diabetes Association. Position statement . Standards of Medical Care in Diabetes – 2013 . Diabetes Care36 ( Suppl. 1 ), S11 – S66 ( 2013 ).
- Mancia G , LaurentS, Agabiti-RoseiEet al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document . Blood Press.18, 308 – 347 ( 2009 ).
- Law MR , MorrisJK, WaldNJ . Use of BP lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies . BMJ338, b1665 ( 2009 ).
- Aronow WS . Might losartan reduce sudden cardiac death in diabetic patients with hypertension?Lancet362, 591 – 592 ( 2003 ).
- Carlberg B , SamuelsonO, LindholmLH . Atenolol in hypertension: is it a wise choice?Lancet364, 1684 – 1689 ( 2004 ).
- Aronow WS . Current role of beta blockers in the treatment of hypertension . Expert Opin. Pharmacother.11, 2599 – 2607 ( 2010 ).
- Agodoa LY , AppelL, BakrisGLet al. Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephrosclerosis. A randomized controlled trial . JAMA285, 2719 – 2728 ( 2001 ).
- Yusuf S , TeoKK, PogueJet al. Telmisartan, ramipril, or both in patients at high risk for vascular events . N. Engl. J. Med.358, 1547 – 1559 ( 2008 ).